Sapropterin, when administered, is phosphorylated in the body to become sapropterin dihydrochloride, which then acts as a synthetic cofactor for nitric oxide synthase (NOS) [1]. This process is critical for tetrahydrobiopterin (BH4) production [2]. BH4 is an essential cofactor for several enzymes, including phenylalanine hydroxylase (PAH), tyrosine hydroxylase, and tryptophan hydroxylase [3].
How Does Sapropterin Help Phenylketonuria (PKU) Patients?
Sapropterin dihydrochloride is a pharmaceutical product used to treat phenylketonuria (PKU) in adults and children aged 4 years and older [4]. PKU is a rare genetic disorder characterized by the inability to properly metabolize phenylalanine, an amino acid found in protein [4][5]. In individuals with PKU, phenylalanine builds up in the blood to harmful levels [5]. Sapropterin works by increasing the activity of PAH, the enzyme deficient in PKU [3]. By improving PAH activity, sapropterin helps reduce phenylalanine levels in the blood [3].
What is BH4 and Why is it Important?
Tetrahydrobiopterin (BH4) is a naturally occurring molecule in the body that acts as a cofactor for several important enzymes [3][6]. These enzymes are involved in the synthesis of neurotransmitters, such as dopamine and serotonin, and in the metabolism of amino acids [3][6]. BH4 is also crucial for nitric oxide (NO) production, which plays a role in vasodilation and other physiological processes [6]. A deficiency in BH4 can lead to elevated phenylalanine levels and neurological issues [6].
What are the Different Forms of Sapropterin?
Sapropterin dihydrochloride is the active pharmaceutical ingredient. It is formulated into tablets for oral administration under brand names such as Kuvan [4][7].
When Does Sapropterin's Patent Protection Expire?
Information regarding the specific patent expiry dates for sapropterin is available through resources like DrugPatentWatch.com. These dates are crucial for understanding potential market entry for generic versions [8].
Who Manufactures Sapropterin?
Sapropterin dihydrochloride is manufactured by BioMarin Pharmaceutical Inc. [7].
What Clinical Data Supports Sapropterin's Use?
Clinical studies have demonstrated that sapropterin can effectively lower blood phenylalanine levels in a significant proportion of patients with PKU [3][9]. These studies have also investigated its efficacy in different age groups and in conjunction with dietary therapy [9].
Are There Any Risks or Side Effects Associated with Sapropterin?
The use of sapropterin can be associated with side effects. Common adverse events reported in clinical trials include headache, nausea, diarrhea, and upper respiratory tract infection [4]. Patients and healthcare providers should be aware of potential risks and monitor for adverse reactions [4].